WILLIAM A JR JONES
CIK 1373097 · Chief Commercial Officer · last filed 2026-08-03
WILLIAM A JR JONES is a Chief Commercial Officer who has filed 22 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for APMD, was dated Aug 3, 2026. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $709.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$709.9K
7
22
-$2.29M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APMD | Director | — | — | — | $0 | 1 | 2026-08-03 |
| ANNX | Director | — | $4.89 | — | $0 | 3 | 2026-06-15 |
| APGE | Director | — | $135.08 | — | $0 | 3 | 2026-06-11 |
| NAMSW | Chief Commercial Officer | 43,000 | $16.51 | $709.9K | $0 | 2 | 2025-01-07 |
| Akili, Inc. (AKLI) Delisted | Director | — | $0.43 | — | $0 | 2 | 2023-05-04 |
| BHVN | CCO-Migraine & Common Disease | 0 | $15.74 | $0 | -$2.29M | 9 | 2022-10-03 |
| NITROMED INC (NTMD) Delisted | Vice President | 56,818 | — | — | $0 | 2 | 2007-09-18 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-03 | APMD | Mixed | — | $0 | EDGAR |
| 2026-06-15 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2026-06-11 | APGE | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | APGE | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2025-01-10 | ANNX | Grant (A) | — | $0 | EDGAR |
| 2025-01-07 | NAMSW | Grant (A) | +43,000 | $0 | EDGAR |
| 2025-01-06 | NAMSW | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | APGE | Grant (A) | — | $0 | EDGAR |
| 2023-05-04 | Akili, Inc. (AKLI) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.